Autophagy and Heart Failure: A Possible Role for Homocysteine

Cell Biochemistry and Biophysics

Volumn 62, Issue 1, 2012, Pages 1-11

  Vacek, Thomas P ^a   Vacek, Jonathan C ^a   Tyagi, Neetu ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Beclin 1; BNIP3; Calpain 1; Ischemia reperfusion injury; Mitochondrial pore transition; Oxidative stress

Indexed keywords

CALCIUM; HOMOCYSTEINE; REACTIVE OXYGEN METABOLITE;

AUTOPHAGY; HEART FAILURE; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; REPERFUSION INJURY; REVIEW;

AUTOPHAGY; CALCIUM; HEART FAILURE; HOMOCYSTEINE; HUMANS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 84855586208     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9281-6     Document Type: Review

References (118)

1. Srivastava, D., & Ivey, K. N. (2006). Potential of stem-cell-based therapies for heart disease. Nature, 441, 1097-1099.
2. Terman, A., & Brunk, U. T. (2006). Oxidative stress, accumulation of biological 'garbage', and aging. Antioxidants & Redox Signaling, 8, 197-204.
3. Yorimitsu, T., & Klionsky, D. J. (2005). Autophagy: Molecular machinery for self-eating. Cell Death and Differentiation, 12(Suppl 2), 1542-1552.
4. Stromhaug, P. E., & Seglen, P. O. (1993). Evidence for acidity of prelysosomal autophagic/endocytic vacuoles (amphisomes). Biochemical Journal, 291(Pt 1), 115-121.
5. Kundu, M., & Thompson, C. B. (2005). Macroautophagy versus mitochondrial autophagy: A question of fate? Cell Death and Differentiation, 12(Suppl 2), 1484-1489.
6. Massey, A. C., Zhang, C., & Cuervo, A. M. (2006). Chaperone-mediated autophagy in aging and disease. Current Topics in Developmental Biology, 73, 205-235.
7. Uttenweiler, A., Schwarz, H., & Mayer, A. (2005). Microautophagic vacuole invagination requires calmodulin in a Ca2+-independent function. Journal of Biological Chemistry, 280, 33289-33297.
8. Yang, Y. P., Liang, Z. Q., Gu, Z. L., & Qin, Z. H. (2005). Molecular mechanism and regulation of autophagy. Acta Pharmacologica Sinica, 26, 1421-1434.
9. Kolb, J. P. (2000). Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia. Leukemia, 14, 1685-1694.
10. Melino, G., Catani, M. V., Corazzari, M., Guerrieri, P., & Bernassola, F. (2000). Nitric oxide can inhibit apoptosis or switch it into necrosis. Cellular and Molecular Life Sciences, 57, 612-622.
11. Rabkin, S. W., & Kong, J. Y. (2000). Nitroprusside induces cardiomyocyte death: Interaction with hydrogen peroxide. American Journal of Physiology. Heart and Circulatory Physiology, 279, H3089-H3100.
12. Stefanelli, C., Pignatti, C., Tantini, B., Stanic, I., Bonavita, F., Muscari, C., et al. (1999). Nitric oxide can function as either a killer molecule or an antiapoptotic effector in cardiomyocytes. Biochimica et Biophysica Acta, 1450, 406-413.
13. Tomanek, R. J., Trout, J. J., & Lauva, I. K. (1984). Cytochemistry of myocardial structures related to degenerative processes in spontaneously hypertensive and normotensive rats. Journal of Molecular and Cellular Cardiology, 16, 227-237.
14. Pfeifer, U., Fohr, J., Wilhelm, W., & Dammrich, J. (1987). Short-term inhibition of cardiac cellular autophagy by isoproterenol. Journal of Molecular and Cellular Cardiology, 19, 1179-1184.
15. Dammrich, J., & Pfeifer, U. (1983). Cardiac hypertrophy in rats after supravalvular aortic constriction. II. Inhibition of cellular autophagy in hypertrophying cardiomyocytes. Virchows Archiv. B, Cell Pathology Including Molecular Pathology, 43, 287-307.
16. Lu, L., Wu, W., Yan, J., Li, X., Yu, H., & Yu, X. (2009). Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure. International Journal of Cardiology, 134, 82-90.
17. Hamacher-Brady, A., Brady, N. R., Logue, S. E., Sayen, M. R., Jinno, M., Kirshenbaum, L. A., et al. (2007). Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death and Differentiation, 14, 146-157.
18. Elmore, S. P., Qian, T., Grissom, S. F., & Lemasters, J. J. (2001). The mitochondrial permeability transition initiates autophagy in rat hepatocytes. FASEB Journal, 15, 2286-2287.
19. Terman, A., Dalen, H., Eaton, J. W., Neuzil, J., & Brunk, U. T. (2003). Mitochondrial recycling and aging of cardiac myocytes: The role of autophagocytosis. Experimental Gerontology, 38, 863-876.
20. Beckman, K. B., & Ames, B. N. (1998). The free radical theory of aging matures. Physiological Reviews, 78, 547-581.
21. Beregi, E., Regius, O., Huttl, T., & Gobl, Z. (1988). Age-related changes in the skeletal muscle cells. Zeitschrift für Gerontologie, 21, 83-86.
22. Coleman, R., Silbermann, M., Gershon, D., & Reznick, A. Z. (1987). Giant mitochondria in the myocardium of aging and endurance-trained mice. Gerontology, 33, 34-39.
23. Kadenbach, B., Munscher, C., Frank, V., Muller-Hocker, J., & Napiwotzki, J. (1995). Human aging is associated with stochastic somatic mutations of mitochondrial DNA. Mutation Research, 338, 161-172.
24. Ozawa, T. (1997). Genetic and functional changes in mitochondria associated with aging. Physiological Reviews, 77, 425-464.
25. Sachs, H. G., Colgan, J. A., & Lazarus, M. L. (1977). Ultrastructure of the aging myocardium: A morphometric approach. American Journal of Anatomy, 150, 63-71.
26. Vanneste, J., & van den Bosch de Aguilar, P. (1981). Mitochondrial alterations in the spinal ganglion neurons in ageing rats. Acta Neuropathologica, 54, 83-87.
27. Wallace, D. C. (1997). Mitochondrial DNA in aging and disease. Scientific American, 277, 40-47.
28. Terman, A., Dalen, H., Eaton, J. W., Neuzil, J., & Brunk, U. T. (2004). Aging of cardiac myocytes in culture: Oxidative stress, lipofuscin accumulation, and mitochondrial turnover. Annals of the New York Academy of Sciences, 1019, 70-77.
29. Gozuacik, D., & Kimchi, A. (2004). Autophagy as a cell death and tumor suppressor mechanism. Oncogene, 23, 2891-2906.
30. Lamkanfi, M., Declercq, W., Kalai, M., Saelens, X., & Vandenabeele, P. (2002). Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death and Differentiation, 9, 358-361.
31. Martinon, F., & Tschopp, J. (2004). Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases. Cell, 117, 561-574.
32. Klionsky, D. J., Cregg, J. M., Dunn, W. A., Jr., Emr, S. D., Sakai, Y., Sandoval, I. V., et al. (2003). A unified nomenclature for yeast autophagy-related genes. Developmental Cell, 5, 539-545.
33. Levine, B., & Yuan, J. (2005). Autophagy in cell death: An innocent convict? Journal of Clinical Investigation, 115, 2679-2688.
34. Tyagi, N., Gillespie, W., Vacek, J. C., Sen, U., Tyagi, S. C., & Lominadze, D. (2009). Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway. Journal of Cellular Physiology, 220, 257-266.
35. Kundu, S., Kumar, M., Sen, U., Mishra, P. K., Tyagi, N., Metreveli, N., et al. (2009). Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice. Journal of Cellular Biochemistry, 106, 119-126.
36. Dimmeler, S., Haendeler, J., Nehls, M., & Zeiher, A. M. (1997). Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. Journal of Experimental Medicine, 185, 601-607.
37. Kong, J. Y., & Rabkin, S. W. (2000). Angiotensin II does not induce apoptosis but rather prevents apoptosis in cardiomyocytes. Peptides, 21, 1237-1247.
38. Choi, B. M., Pae, H. O., Jang, S. I., Kim, Y. M., & Chung, H. T. (2002). Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. Journal of Biochemistry and Molecular Biology, 35, 116-126.
39. Kroemer, G., El-Deiry, W. S., Golstein, P., Peter, M. E., Vaux, D., Vandenabeele, P., et al. (2005). Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death. Cell Death and Differentiation, 12(Suppl 2), 1463-1467.
40. Nicholson, D. W. (1999). Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death and Differentiation, 6, 1028-1042.
41. Tyagi, N., Ovechkin, A. V., Lominadze, D., Moshal, K. S., & Tyagi, S. C. (2006). Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia. Journal of Cellular Biochemistry, 98, 1150-1162.
42. Yuan, H., Perry, C. N., Huang, C., Iwai-Kanai, E., Carreira, R. S., Glembotski, C. C., et al. (2009). LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection. American Journal of Physiology. Heart and Circulatory Physiology, 296, H470-H479.
43. Tracy, K., Dibling, B. C., Spike, B. T., Knabb, J. R., Schumacker, P., & Macleod, K. F. (2007). BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Molecular and Cellular Biology, 27, 6229-6242.
44. Band, M., Joel, A., Hernandez, A., & Avivi, A. (2009). Hypoxia-induced BNIP3 expression and mitophagy: In vivo comparison of the rat and the hypoxia-tolerant mole rat, Spalax ehrenbergi. FASEB Journal, 23, 2327-2335.
45. Nakatogawa, H., Suzuki, K., Kamada, Y., & Ohsumi, Y. (2009). Dynamics and diversity in autophagy mechanisms: Lessons from yeast. Nature Reviews. Molecular Cell Biology, 10, 458-467.
46. Sekito, T., Kawamata, T., Ichikawa, R., Suzuki, K., & Ohsumi, Y. (2009). Atg17 recruits Atg9 to organize the pre-autophagosomal structure. Genes Cells, 14, 525-538.
47. Otto, G. P., Wu, M. Y., Kazgan, N., Anderson, O. R., & Kessin, R. H. (2004). Dictyostelium macroautophagy mutants vary in the severity of their developmental defects. Journal of Biological Chemistry, 279, 15621-15629.
48. Thompson, A. R., Doelling, J. H., Suttangkakul, A., & Vierstra, R. D. (2005). Autophagic nutrient recycling in Arabidopsis directed by the ATG8 and ATG12 conjugation pathways. Plant Physiology, 138, 2097-2110.
49. Mizushima, N., Kuma, A., Kobayashi, Y., Yamamoto, A., Matsubae, M., Takao, T., et al. (2003). Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. Journal of Cell Science, 116, 1679-1688.
50. Yousefi, S., Perozzo, R., Schmid, I., Ziemiecki, A., Schaffner, T., Scapozza, L., et al. (2006). Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nature Cell Biology, 8, 1124-1132.
51. Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., et al. (2007). The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nature Medicine, 13, 619-624.
52. Thornberry, N. A., & Lazebnik, Y. (1998). Caspases: Enemies within. Science, 281, 1312-1316.
53. Zhu, H., Tannous, P., Johnstone, J. L., Kong, Y., Shelton, J. M., Richardson, J. A., et al. (2007). Cardiac autophagy is a maladaptive response to hemodynamic stress. Journal of Clinical Investigation, 117, 1782-1793.
54. Takagi, H., Matsui, Y., Hirotani, S., Sakoda, H., Asano, T., & Sadoshima, J. (2007). AMPK mediates autophagy during myocardial ischemia in vivo. Autophagy, 3, 405-407.
55. Matsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., Asano, T., et al. (2007). Distinct roles of autophagy in the heart during ischemia and reperfusion: Roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circulation Research, 100, 914-922.
56. Arad, M., Seidman, C. E., & Seidman, J. G. (2007). AMP-activated protein kinase in the heart: Role during health and disease. Circulation Research, 100, 474-488.
57. Wang, X., Osinska, H., Dorn, G. W., Nieman, M., Lorenz, J. N., Gerdes, A. M., et al. (2001). Mouse model of desmin-related cardiomyopathy. Circulation, 103, 2402-2407.
58. Feng, Z., Zhang, H., Levine, A. J., & Jin, S. (2005). The coordinate regulation of the p53 and mTOR pathways in cells. Proceedings of the National Academy of Sciences of the United States of America, 102, 8204-8209.
59. Russell, R. R., I. I. I., Li, J., Coven, D. L., Pypaert, M., Zechner, C., Palmeri, M., et al. (2004). AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. Journal of Clinical Investigation, 114, 495-503.
60. Xing, Y., Musi, N., Fujii, N., Zou, L., Luptak, I., Hirshman, M. F., et al. (2003). Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. Journal of Biological Chemistry, 278, 28372-28377.
61. Dosenko, V. E., Nagibin, V. S., Tumanovska, L. V., & Moibenko, A. A. (2006). Protective effect of autophagy in anoxia-reoxygenation of isolated cardiomyocyte? Autophagy, 2, 305-306.
62. Dann, S. G., & Thomas, G. (2006). The amino acid sensitive TOR pathway from yeast to mammals. FEBS Letters, 580, 2821-2829.
63. Scott, R. C., Schuldiner, O., & Neufeld, T. P. (2004). Role and regulation of starvation-induced autophagy in the Drosophila fat body. Developmental Cell, 7, 167-178.
64. Wang, C., Wang, Y., McNutt, M. A., & Zhu, W. G. (2011). Autophagy process is associated with anti-neoplastic function. Acta Biochimica et Biophysica Sinica (Shanghai), 43(6), 425-432.
65. Obara, K., Sekito, T., & Ohsumi, Y. (2006). Assortment of phosphatidylinositol 3-kinase complexes-Atg14p directs association of complex I to the pre-autophagosomal structure in Saccharomyces cerevisiae. Molecular Biology of the Cell, 17, 1527-1539.
66. Rameh, L. E., & Cantley, L. C. (1999). The role of phosphoinositide 3-kinase lipid products in cell function. Journal of Biological Chemistry, 274, 8347-8350.
67. Petiot, A., Ogier-Denis, E., Blommaart, E. F., Meijer, A. J., & Codogno, P. (2000). Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. Journal of Biological Chemistry, 275, 992-998.
68. Matsui, T., Li, L., del, M., Fukui, Y., Franke, T. F., Hajjar, R. J., et al. (1999). Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation, 100, 2373-2379.
69. Liang, C., Feng, P., Ku, B., Dotan, I., Canaani, D., Oh, B. H., et al. (2006). Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nature Cell Biology, 8, 688-699.
70. Lindmo, K., & Stenmark, H. (2006). Regulation of membrane traffic by phosphoinositide 3-kinases. Journal of Cell Science, 119, 605-614.
71. Gu, Y., Wang, C., & Cohen, A. (2004). Effect of IGF-1 on the balance between autophagy of dysfunctional mitochondria and apoptosis. FEBS Letters, 577, 357-360.
72. Aki, T., Yamaguchi, K., Fujimiya, T., & Mizukami, Y. (2003). Phosphoinositide 3-kinase accelerates autophagic cell death during glucose deprivation in the rat cardiomyocyte-derived cell line H9c2. Oncogene, 22, 8529-8535.
73. Takemura, G., Maruyama, R., Goto, K., Kanamori, H., Tsujimoto, A., Minatoguchi, S., et al. (2009). Fate of isolated adult cardiomyocytes undergoing starvation-induced autophagic degeneration. Autophagy, 5, 90-92.
74. Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E. L., Hartmann, D., Lullmann-Rauch, R., et al. (2000). Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature, 406, 902-906.
75. Fukuda, M. (1991). Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. Journal of Biological Chemistry, 266, 21327-21330.
76. Anderson, R. G. (1989). Postembedding detection of acidic compartments. Methods in Cell Biology, 31, 463-472.
77. Danon, M. J., Oh, S. J., DiMauro, S., Manaligod, J. R., Eastwood, A., Naidu, S., et al. (1981). Lysosomal glycogen storage disease with normal acid maltase. Neurology, 31, 51-57.
78. Eskelinen, E. L. (2006). Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Molecular Aspects of Medicine, 27, 495-502.
79. Pfeifer, U., & Strauss, P. (1981). Autophagic vacuoles in heart muscle and liver. A comparative morphometric study including circadian variations in meal-fed rats. Journal of Molecular and Cellular Cardiology, 13, 37-49.
80. Chen, Y., McMillan-Ward, E., Kong, J., Israels, S. J., & Gibson, S. B. (2008). Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death and Differentiation, 15, 171-182.
81. Kiffin, R., Bandyopadhyay, U., & Cuervo, A. M. (2006). Oxidative stress and autophagy. Antioxidants & Redox Signaling, 8, 152-162.
82. Kurz, T., Terman, A., Gustafsson, B., & Brunk, U. T. (2008). Lysosomes and oxidative stress in aging and apoptosis. Biochimica et Biophysica Acta, 1780, 1291-1303.
83. Gurusamy, N., & Das, D. K. (2009). Autophagy, redox signaling, and ventricular remodeling. Antioxidants & Redox Signaling, 11, 1975-1988.
84. Comstock, K. L., Krown, K. A., Page, M. T., Martin, D., Ho, P., Pedraza, M., et al. (1998). LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: Obligatory role for CD14 in mediating the LPS response. Journal of Molecular and Cellular Cardiology, 30, 2761-2775.
85. Iwai-Kanai, E., Hasegawa, K., Fujita, M., Araki, M., Yanazume, T., Adachi, S., et al. (2002). Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. Journal of Cellular Physiology, 190, 54-62.
86. Kawakami, T., Inagi, R., Takano, H., Sato, S., Ingelfinger, J. R., Fujita, T., et al. (2009). Endoplasmic reticulum stress induces autophagy in renal proximal tubular cells. Nephrology, Dialysis, Transplantation, 24, 2665-2672.
87. Chu, C. T., Zhu, J., & Dagda, R. (2007). Beclin 1-independent pathway of damage-induced mitophagy and autophagic stress: Implications for neurodegeneration and cell death. Autophagy, 3, 663-666.
88. Scherz-Shouval, R., Shvets, E., Fass, E., Shorer, H., Gil, L., & Elazar, Z. (2007). Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO Journal, 26, 1749-1760.
89. Kirkland, R. A., Adibhatla, R. M., Hatcher, J. F., & Franklin, J. L. (2002). Loss of cardiolipin and mitochondria during programmed neuronal death: Evidence of a role for lipid peroxidation and autophagy. Neuroscience, 115, 587-602.
90. Kim, I., Rodriguez-Enriquez, S., & Lemasters, J. J. (2007). Selective degradation of mitochondria by mitophagy. Archives of Biochemistry and Biophysics, 462, 245-253.
91. Assuncao, G. C., & Linden, R. (2004). Programmed cell deaths. Apoptosis and alternative deathstyles. European Journal of Biochemistry, 271, 1638-1650.
92. Daido, S., Kanzawa, T., Yamamoto, A., Takeuchi, H., Kondo, Y., & Kondo, S. (2004). Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Research, 64, 4286-4293.
93. Hoyer-Hansen, M., Bastholm, L., Szyniarowski, P., Campanella, M., Szabadkai, G., Farkas, T., et al. (2007). Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Molecular Cell, 25, 193-205.
94. Dalton, T. P., Shertzer, H. G., & Puga, A. (1999). Regulation of gene expression by reactive oxygen. Annual Review of Pharmacology and Toxicology, 39, 67-101.
95. Li, Y. F., Cornish, K. G., & Patel, K. P. (2003). Alteration of NMDA NR1 receptors within the paraventricular nucleus of hypothalamus in rats with heart failure. Circulation Research, 93, 990-997.
96. D'Amico, M., Di, F. C., Rossi, F., & Rossi, F. (1999). Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists. European Journal of Pharmacology, 366, 167-174.
97. Folbergrova, J. (1994). NMDA and not non-NMDA receptor antagonists are protective against seizures induced by homocysteine in neonatal rats. Experimental Neurology, 130, 344-350.
98. Gao, X., Xu, X., Pang, J., Zhang, C., Ding, J. M., Peng, X., et al. (2007). NMDA receptor activation induces mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardiomyocytes. Physiological Research, 56, 559-569.
99. Huang, C. F., & Su, M. J. (1999). Positive inotropic action of NMDA receptor antagonist (+)-MK801 in rat heart. Journal of Biomedical Science, 6, 387-398.
100. Krainc, D., Bai, G., Okamoto, S., Carles, M., Kusiak, J. W., Brent, R. N., et al. (1998). Synergistic activation of the N-methyl-d-aspartate receptor subunit 1 promoter by myocyte enhancer factor 2C and Sp1. Journal of Biological Chemistry, 273, 26218-26224.
101. Qureshi, I., Chen, H., Brown, A. T., Fitzgerald, R., Zhang, X., Breckenridge, J., et al. (2005). Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor. Vascular Medicine, 10, 215-223.
102. Moshal, K. S., Kumar, M., Tyagi, N., Mishra, P. K., Metreveli, N., Rodriguez, W. E., et al. (2009). Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1. American Journal of Physiology. Heart and Circulatory Physiology, 296, H887-H892.
103. Brar, S. S., Kennedy, T. P., Whorton, A. R., Sturrock, A. B., Huecksteadt, T. P., Ghio, A. J., et al. (2001). Reactive oxygen species from NAD(P)H: quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells. American Journal of Physiology. Cell Physiology, 280, C659-C676.
104. Wang, G., Siow, Y. L., & O, K. (2000). Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: A possible role for protein kinase C. Biochemical Journal, 352(Pt 3), 817-826.
105. Inoue, I., Noji, S., Awata, T., Takahashi, K., Nakajima, T., Sonoda, M., et al. (1998). Bezafibrate has an antioxidant effect: Peroxisome proliferator-activated receptor alpha is associated with Cu2+, Zn2+-superoxide dismutase in the liver. Life Sciences, 63, 135-144.
106. Brude, I. R., Finstad, H. S., Seljeflot, I., Drevon, C. A., Solvoll, K., Sandstad, B., et al. (1999). Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers. European Journal of Clinical Investigation, 29, 100-108.
107. Inoue, I., Goto, S., Mizotani, K., Awata, T., Mastunaga, T., Kawai, S., et al. (2000). Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells. Life Sciences, 67, 863-876.
108. Inoue, I., Goto, S., Matsunaga, T., Nakajima, T., Awata, T., Hokari, S., et al. (2001). The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism, 50, 3-11.
109. Poynter, M. E., & Daynes, R. A. (1998). Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. Journal of Biological Chemistry, 273, 32833-32841.
110. Mujumdar, V. S., Aru, G. M., & Tyagi, S. C. (2001). Induction of oxidative stress by homocyst(e)ine impairs endothelial function. Journal of Cellular Biochemistry, 82, 491-500.
111. Zhang, X., Li, H., Jin, H., Ebin, Z., Brodsky, S., & Goligorsky, M. S. (2000). Effects of homocysteine on endothelial nitric oxide production. American Journal of Physiology. Renal Physiology, 279, F671-F678.
112. Berman, R. S., & Martin, W. (1993). Arterial endothelial barrier dysfunction: Actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system. British Journal of Pharmacology, 108, 920-926.
113. Marx, N., Sukhova, G., Murphy, C., Libby, P., & Plutzky, J. (1998). Macrophages in human atheroma contain PPARgamma: Differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. American Journal of Pathology, 153, 17-23.
114. McGregor, D., Shand, B., & Lynn, K. (2000). A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease. Nephron, 85, 215-220.
115. Moshal, K. S., Singh, M., Sen, U., Rosenberger, D. S., Henderson, B., Tyagi, N., et al. (2006). Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. American Journal of Physiology. Heart and Circulatory Physiology, 291, H2825-H2835.
116. Zhou, H. Z., Ma, X., Gray, M. O., Zhu, B. Q., Nguyen, A. P., Baker, A. J., et al. (2007). Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction. Biochemical and Biophysical Research Communications, 358, 189-195.
117. Moshal, K. S., Metreveli, N., Frank, I., & Tyagi, S. C. (2008). Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia. Current Vascular Pharmacology, 6, 84-92.
118. Moshal, K. S., Tipparaju, S. M., Vacek, T. P., Kumar, M., Singh, M., Frank, I. E., et al. (2008). Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. American Journal of Physiology. Heart and Circulatory Physiology, 295, H890-H897.